AI Classification
PositiveFine-tuned Classification
PositiveCannabinoid receptor 2 agonist, lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis
P453 A study on patient and healthcare provider experiences with outpatient sexual and reproductive healthcare for adults with cystic fibrosis: insights from a single-center study
Targeting cannabinoid receptor 1 for antagonism in pro-fibrotic alveolar macrophages mitigates pulmonary fibrosis
Clinical factors associated with smoking cessation among smokers with Chronic Obstructive Pulmonary Disease by sex: Longitudinal analyses from French smoking cessation services
Harmonization of clinical practice guidelines for primary prevention and screening: actionable recommendations and resources for primary care
Patent review of cannabinoid receptor type 2 (CB2R) modulators (2016-present)